Neuronal cell death in human neurodegenerative diseases and their animal/cell models

Apoptosis in Health and Disease: Clinical and Therapeutic Aspects

Volumn , Issue , 2005, Pages 96-155

  Martin, Lee J ^a   Liu, Zhiping ^a   Troncoso, Juan ^a   Price, Donald L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845410959     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511663543.005     Document Type: Chapter

References (350)

1. Adamec, E., Vonsattel, J. P., and Nixon, R. A. (1999). DNA strand breaks in Alzheimer’s disease. Brain Res., 849, 67-77.
2. Al-Abdulla, N. A. and Martin, L. J. (1998).Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am. J. Pathol., 153, 447-56.
3. Al-Abdulla, N. A., Portera-Cailliau, C., and Martin, L. J. (1998). Occipital cortex ablation in adult rat causes retrograde neuronal death in the lateral geniculate nucleus that resembles apoptosis. Neuroscience, 86, 191-209.
4. Aloyz, R. S., Bamji, S. X., Pozniak, C. D. et al. (1998). p53 is essential for developmental neuron death regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol., 143, 1691-703.
5. Alvarez, A., Munoz, J. P., and Maccioni, R. B. (2001). A cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons. Exp. Cell Res., 264, 266-74.
6. Alves da Costa, C., Paitel, E., Vincent, B., and Checler, F. (2002). Alpha-synuclein lowers p53- dependent apoptotic of neuronal cell: abolishment by 6-hydroxydopamine and implication for Parkinson’s disease. J. Biol. Chem., 277, 50980-4.
7. Ameisen, J. C. (2002). On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Diff., 9, 367-93.
8. Amin, F., Bowen, I. D., Szegedi, Z., Mihalik, R., and Szende, B. (2000). Apoptotic and nonapoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells. Cell Biol. Intl., 24, 253-60.
9. Anderson, A. J., Su, J. H., and Cotman, C.W. (1996). DNA damage and apoptosis in Alzheimer’s disease: colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci., 16, 1710-19.
10. Anglade, P., Vyas, S., Javoy-Agid, F. et al. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol. Histopathol., 12, 25-31.
11. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E. et al. (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 15, 961-73.
12. Antonsson, B., Conti, F., Ciavatta, A. et al. (1997). Inhibition of bax channel-forming activity by bcl-2. Science, 277, 370-2.
13. Barron, K. D., Means, E. D., and Larsen, E. (1973). Ultrastructure of retrograde degeneration in thalamus of rat. I. Neuronal somata and dendrites. J. Neuropathol. Exp. Neurol., 32, 218-44.
14. Beckman, J. S., Carson, M., Smith, C.D., and Koppenol, W.H.(1993). ALS, SOD and peroxynitrite. Nature, 364, 548.
15. Beckman, J. S., Estōvez, A. G., Crow, J. P., and Barbeito, L. (2001). Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci., 24 (suppl), S15-S20.
16. Behl, C., Davis, J. B., Klier, F. G., and Schubert, D. (1994). Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res., 645, 253-64.
17. Bendotti, C., Calvaresi, N., Chiveri, L. et al. (2001). Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci., 191, 25-33.
18. Beresford, P. J., Zhang, D., Oh, D. Y. et al. (2001).GranzymeAactivates an endoplasmic reticulum associated caspase-independent nuclease to induce single-stranded DNA nicks. J. Biol. Chem., 276, 43285-93.
19. Bilsland, J., Roy, S., Xanthoudakis, S. et al. (2002). Caspase inhibitors attenuate 1-methyl-4- phenylpyridinum toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci., 22, 2637-49.
20. Blum, D., Wu, Y., Nissou, M-F., Arnaud, S., Benabid, A.-L., and Verna, J.-M. (1997). p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Res., 751, 139-42.
21. Bonfanti, L., Strettoi, E., Chierzi, S. et al. (1996). Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J. Neurosci., 16, 4186-94.
22. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S. A. (1995). Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with Nmethyl- D-aspartate or nitric oxide/superoxide in cortical cell culture. Proc. Natl. Acad. Sci. USA, 92, 7162-6.
23. Bradley, W. G. and Krasin, F. (1982). A new hypothesis of the etiology of amyotrophic lateral sclerosis. The DNA hypothesis. Arch. Neurol., 39, 677-80.
24. Bucciantini, M., Giannoni, E., Chiti, F. et al. (2002). Inherent toxicity of aggregates implies a common mechanism for misfolding diseases. Nature, 416, 507-11.
25. Bursch, W. (2001). The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Diff., 8, 569-81.
26. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. (1990). Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis, 11, 847-53.
27. Bursztajn, S., DeSouza, R., McPhie, D. L. et al. (1998). Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer diseasemutant does not enhance apoptosis. J. Neurosci., 18, 9790-9.
28. Calhoun, M. E., Wiederhold, K. H., Abramowski, D. et al. (1998). Neuron loss in APP transgenic mice. Nature, 395, 755-6.
29. Campion, D., Flaman, J. M., Brice, A. et al. (1995).Mutations of the presenilin 1 gene in families with early-onset Alzheimer’s disease. Hum. Mol. Genet., 4, 2373-7.
30. Cardone, M. H., Roy, N., Stennicke, H. R. et al. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21.
31. Cardone, M. H., Salvesen, G. S., Widmann, C., Johnson, G., and Frisch, S. M. (1997). The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell, 90, 315-23.
32. Casaccia-Bonnefil, P., Carter, B. D., Dobrowsky, R. T., and Chao, M. V. (1996). Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature, 383, 716-19.
33. Casley, C. S., Land, J. M., Sharpe, M. A., Clark, J. B., Duchen, M. R., and Canevari, L. (2002). β-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis., 10, 258-67.
34. Cataldo, A. M., Hamilton, D. J., and Nixon, R. A. (1994). Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer’s disease. Brain Res., 640, 68-80.
35. Chan, S. L., Culmsee, C., Haughey, N., Klapper, W., and Mattson, M. P. (2002). Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12. Neurobiol. Dis., 11, 2-19.
36. Chang, Y.-C., Lee, Y.-S., Tejima, T. et al. (1998). Mdm-2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Diff., 9, 79-84.
37. Chartier-Harlin, M.-C., Crawford, F., Houlden, H. et al. (1991). Early-onset Alzheimer’s disease caused by mutations at codon 717 of the β -amyloid precursor protein gene. Nature, 353, 844-6.
38. Choi, D.W. (1992). Excitotoxic cell death. J. Neurobiol., 23, 1261-76.
39. Chu-Wang, I.-W. and Oppenheim, R.W. (1978). Cell death of motoneurons in the chick embryo spinal cord. I. A light and electron microscopic study of naturally occurring and induced cell loss during development. J. Comp. Neurol., 177, 33-58.
40. Clarke, P. G. H. (1990). Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol., 181, 195-213.
41. Cory, S. and Adams, J. M. (2002). The bcl-2 family: regulators of the cellular life-or-death switch. Nat. Rev., 2, 647-56.
42. Crocker, S. J., Wigle, N., Liston, P. et al. (2001).NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson’s disease. Eur. J. Neurosci., 14, 391-400.
43. Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem. J., 341, 233-49.
44. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., and Tsai, L.-H. (2003).Aberrant Cdk5 activation by p25 triggers pathological events leading to neuro degeneration and neurofibrillary tangles. Neuron, 40, 471-83.
45. Culmsee, C., Zhu, X., Yu, Q. S. et al. (2001). A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem., 77, 220-8.
46. Danial, N. N., Gramm, C. F., Scorrano, L. et al. (2003). Bad and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature, 424, 952-6.
47. Dargusch, R., Piasecki, D., Tan, S., Liu, Y., and Schubert, D. (2001). The role of Bax in glutamateinduced nerve cell death. J. Neurochem., 76, 295-301.
48. Datta, S. R., Dudek, H., Tao, X. et al. (1997). Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-41.
49. Davies, S. W., Turmaine, M., Cozens, B. A. et al. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-48.
50. de Aguilar, J. L. G., Gorden, J. W., Rene, F. et al. (2000). Alteration of the cl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol. Dis., 7, 406-15.
51. Deak, J. C., Cross, J. V., Lewis, M. et al. (1998). Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA, 95, 5595-600.
52. Deckwerth, T. L., Elliott, J. L., Knudson, C. M., Johnson, E. M., Snider, W. D., and Korsmeyer, S. J. (1996). Bax is required for neuronal death after trophic factor deprivation and during development. Neuron, 17, 401-11.
53. DeKosky, S. T. and Scheff, S. W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann. Neurol., 27, 457-64.
54. de laMonte, S., Sohn, Y. K., and Wands, J. R. (1997). Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer’s disease. J. Neurol. Sci., 152, 73-83.
55. de la Monte, S. M., Sohn, Y. K., Ganju, N., and Wands, J. R. (1998). p53- and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest., 78, 401-11.
56. delPeso, L., Gonzlez-Garcia, M., Page, C., Herrera, R., and Nuez, G. (1997). Interleukin-3-induced phosphorylation of bad through the protein kinase Akt. Science, 278, 687-9.
57. Deng, H.-X., Hentati, A., Tainer, J. A. et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science, 261, 1047-51.
58. Desagher, S., Osen-Sand, A., Nichols, A. et al. (1999). Bid-induced conformational change of bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol., 144, 891-901.
59. Dessi, F., Charriaut-Marlangue, C., Khrestchatisky, M., and Ben-Ari, Y. (1993). Glutamateinduced neuronal death is not a programmed cell death in cerebellar culture. J. Neurochem., 60, 1953-5.
60. Deveraux, Q. L., Roy, N., Stennicke, H. R. et al. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J., 17, 2215-23.
61. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumor suppression. Nat. Genet., 19, 348-55.
62. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochromec-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33-42.
63. Dubois-Dauphin, M., Frankowski, H., Tsujimoto, Y., Huarte, J., and Martinou, J.-C. (1994). Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA, 91, 3309-13.
64. Duker, N. J., Sperling, J., Soprano, K. J., Druin, D. P., Davis, A., and Ashworth, R. (2001). β-amyloid protein induces the formation of purine dimers in cellularDNA. J. Cell Biochem., 81, 393-400.
65. English, J., Pearson G., Wilsbacher, J. et al. (1999). New insights into the control of MAP kinase pathways. Exp. Cell Res., 253, 255-70.
66. Ethell, D. W., Kinloch, R., and Green, D. R. (2002). Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity. Curr. Biol., 12, 1595-600.
67. Evans, D. A., Funkenstein, H. H., Albert, M. S. et al. (1989). Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. JAMA, 262, 2551-6.
68. Fan, Z., Beresford, P. J., Oh, D. Y., Zhang, D., and Lieberman, J. (2003). Tumor suppressor NM23- H1 is a granzyme A-activated DNase during TL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell, 112, 659-72.
69. Farlie, P. G., Dringen, R., Rees, S. M., Kannourakis, G., and Bernard, O. (1995). Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA, 92, 4397-401.
70. Fath, T., Eidenmuller, J., and Brandt, R. (2002). Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer’s disease. J. Neurosci., 22, 9733-41.
71. Fernandes, R. S. and Cotter, T. G. (1994). Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem. Pharmacol., 48, 675-81.
72. Ferrante, R. J., Browne, S. E., Shinobu, L. A. et al. (1997). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem., 69, 2064-74.
73. Ferrer, I., Puig, B., Krupinski, J., Carmona, M., and Blanco, R. (2001).FasandFas ligand expression in Alzheimer’s disease. Acta. Neuropathol., 102, 121-31.
74. Fitzmaurice, P. S., Shaw, I. C., Kleiner, H. E. et al. (1996). Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle. Nerve., 19, 797-8.
75. Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J., and Yuan, J. (1997). Inhibition of ICE lows ALS in mice. Nature, 388, 31.
76. Froelich, S., Basun, H., Forsell, C. et al. (1997). Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am. J. Med. Genet., 74, 380-5.
77. Gamliel, A., Teicher, C., Hartmann, T., Beyreuther, K., and Stein, R. (2003). Overexpression of wild-type presenilin 2 or its familial Alzheimer’s disease-associatedmutant does not induce or increase susceptibility to apoptosis in different cells. Neuroscience, 117, 119-28.
78. Gastard, M. C., Troncoso, J. C., and Koliatsos, V. E. (2003). Caspase activation in the limbic cortex of subjects with early Alzheimer’s disease. Ann. Neurol., 54, 393-8.
79. Gervais, F. G., Singaraja, R., Xanthoudakis, S. et al. (2002).Recruitment and activation of caspase- 8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol., 4, 95-105.
80. Gervais, F. G., Xu, D., Robertson, G. S. et al. (1999). Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell, 97, 395-406.
81. Giaccia, A. J. and Kastan, M. B. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Develop., 12, 2973-83.
82. Giasson, B. I., Duda, J. E., Murray, I. V. J. et al. (2000). Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science, 290, 985-9.
83. Gilman, C. P., Chan, S. L., Guo, Z., Zhu, X., Greig, N., and Mattson, M. P. (2003). p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromolecular Med., 3, 159-72.
84. Giovanni, A., Keramaris, E., Morris, E. J. et al. (2000). E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem., 275, 11553-60.
85. Glücksmann, A. (1951). Cell deaths in normal vertebrate ontogeny. Biol. Rev., 26, 59-86.
86. Goate, A., Chartier-Harlin, M.-C., Mullan, M. et al. (1991). Segregation of a missensemutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature, 349, 704-6.
87. Golden, W. C., Brambrink, A. M., Traystman, R. J., and Martin, L. J. (2001). Failure to sustain recovery of Na, K ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Mol. Brain Res., 88, 94-102.
88. Goldschmidt, R. B. and Steward, O. (1980). Preferential neurotoxicity of colchicine for granule cells of the dentate gyrus of adult rat. Proc. Natl. Acad. Sci. USA, 77, 3047-51.
89. Gotz, J., Chen, F., Barmettler, R., and Nitsch, R. M. (2001a). Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem., 276, 529-34.
90. Gotz, J., Chen, F., van Dorpe, J., and Nitsch, R. M. (2001b). Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science, 293, 1491-5.
91. Gomez-Isla, T., Price, J. L., McKeel, D. W. Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J. Neurosci., 16, 4491-500.
92. Guegan, C., Vila, M., Rosoklija, G., Hays, A. P., and Przeborski, S. (2001). Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci., 21, 6569-76.
93. Gwag, B. J., Koh, J. Y., DeMaro, J. A., Ying, H. S., Jacquin, M., and Choi, D. W. (1997). Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience, 77, 393-401.
94. Hackam, A. S., Yassa, A. S., Singaraja, R. et al. (2000). Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J. Biol. Chem., 275, 41299-308.
95. Hakem, R., Hakem, A., Duncan, G. S. et al. (1998). Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94, 339-52.
96. Haldar, S., Jena, N., and Croce, C. M. (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92, 4507-11.
97. Hardy, J. and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science, 297, 353-6.
98. Harper, P. S. (1996). Huntington’s Disease. London: W. B. Saunders.
99. Hartmann, A., Hunot, S., Michel, P. P. et al. (2000). Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease. Proc.Natl. Acad. Sci., 97, 2875-80.
100. Hartmann, A., Michel, P. P., Troadec, J.-D. et al. (2001). Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson’s disease? J. Neurochem., 76, 1785-93.
101. Hayward, C., Colville, S., Swingler, R. J., and Brock, D. J. H. (1999). Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology, 52, 1899-901.
102. He, Y., Lee, T., and Leong, S. K. (2000). 6-hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra. Brain Res., 858, 163-6.
103. Hegde, R., Srinivasula, S. M., Zhang, Z. et al. (2002). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432-8.
104. Hetman, M., Kanning, K., Cavanaugh, J. E., and Xia, Z. (1999).Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem., 2744, 22569-80.
105. Hirsch, T., Marchetti, P., Susin, S. A. et al. (1997). The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene, 15, 1573-81.
106. Hodgson, J. G., Agopyan, N., Gutekunst, C. A. et al. (1999). A YAC mouse model for Huntington’s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 23, 181-92.
107. Holcik, M. (2002). The IAP proteins. Trends Gen., 18, 537-8.
108. Holcik, M., Thompson, C. S., Yaraghi, Z., Lefebvre, C. A., MacKenzie, A. E., and Korneluk, R. G. (1999). The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)- deleted mice display increased vulnerability to kainic acid-induced injury. Proc. Natl. Acad. Sci. USA, 97, 2286-90.
109. Holzer, M., Gartner, U., Klinz, F. J., Narz, F., Heumann, R., and Arendt, T. (2001). Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. I. Mitogen-activated protein kinase cascade. Neuroscience, 105, 1031-40.
110. Hu, Y., Benedict, M. A., Wu, D., Inohara, N., and Núñez, G. (1998). Bcl-xL interacts with Apaf-1 and inhibitsApaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci.USA, 95, 4386-91.
111. The Huntington’s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971-83.
112. Ikonomidou, C., Qin, Y. Q., Labruyere, J., and Olney, J. W. (1996). Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 55, 211-44.
113. Inbal, B., Bialik, S., Sabanay, I., Shani, G., and Kimchi, A. (2002).DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol., 157, 455-68.
114. Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. T. (1997). APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol., 56, 965-73.
115. Ishikawa, Y. and Kitamura, M. (1999). Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem. Biophys. Res. Comm., 2644, 696-701.
116. Iwata, A., Maruyama, M., Kanazawa, I., and Nukina, N. (2001). α-synuclein affects the MAPK pathway and accelerates cell death. J. Biol. Chem., 276, 45320-9.
117. Jellinger, K. A. (1999). Is there apoptosis in Lewy body disease? Acta. Neuropathol., 97, 413-15.
118. Johnson, M. D., Kinoshita, Y., Xiang, H., Ghatan, S., and Morrison, R. S. (1999). Contribution of p53-dependent caspase activation to neuronal cell death declineswith neuronal maturation. J. Neurosci., 19, 2996-3006.
119. Jones, J. M., Datta, P., Srinivasula, S. M. et al. (2003). Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721-7.
120. Jost, C. A., Marin, M. C., and Kaelin, W. G. (1997). P73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-4.
121. Kalaria, R. N. (2003). Dementia comes of age in the developing world. Lancet, 361, 888-9.
122. Kaplan, D. R. and Miller, F. D. (1997). Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol., 9, 213-21.
123. Katzman, R. (1993). Education and the prevalence of dementia and Alzheimer’s disease. Neurology, 43, 13-20.
124. Keilin, D. (1930). Cytochrome and intracellular oxidase. Proc. R. Soc. Lond., 106, 418-44.
125. Kemp, J. A. and McKernan, R. M. (2002).NMD Areceptor pathways as drug targets. Nat. Neurosci. (suppl), 5, 1039-42.
126. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-57.
127. Kim, J. A., Mitsukawa, K., Yamada, M. K., Nishiyama, N., Matsuki, N., and Ikegaya, Y. (2002). Cytoskeletondisruption causes apoptoticdegenerationof dentate granule cells in hippocampal slice cultures. Neuropharmacology, 42, 1109-18.
128. Kim, M., Lee, H. S., LaForet, G. et al. (1999).Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J.Neurosci., 19, 964-73.
129. Kim, T.-W., Pettingell, W. H., Jung, Y.-K., Kovacs, D. M., and Tazi, R. E. (1997). Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protein. Science, 277, 373-6.
130. Kisby, G. E., Miline, J., and Sweatt, C. (1997). Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. NeuroReport, 8, 1337-40.
131. Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., and Taniguchi, T. (1997). Changes of p53 in the brains of patients with Alzheimer’s disease. Biochem. Biophys. Res. Comm., 232, 418-21.
132. Kitamura, Y., Shimohama, S., Kamoshima, W. et al. (1998). Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer’s disease. Brain Res., 780, 260-9.
133. Klein, J. A., Longo-Guess, C. M., Rossmann, M. P. et al. (2002). The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature, 419, 367-74.
134. Klionsky, D. J. and Emr, S. D. (2000). Autophagy as a regulated pathway of cellular degradation. Science, 290, 1717-21.
135. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997). The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science, 275, 1132-6.
136. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer’s disease. Proc. Natl. Acad. Sci. USA, 83, 4044-8.
137. Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M., and Przedborski, S. (1997). Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis, Science, 277, 559-62.
138. Kuida, K., Haydar, T. F., Kuan, C.-Y. et al. (1998). Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell, 94, 325-37.
139. Kuntz, C., Kinoshita, Y., Beal, M. F., Donehower, L. A., and Morrison, R. S. (2000). Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol., 165, 184-90.
140. Kuperstein, F. and Yavin, E. (2002). ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures. Eur. J. Neurosci., 16, 44-54.
141. Kure, S., Tominaga, T., Yoshimoto, T., Tada, K., and Narisawa, K. (1991). Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun., 179, 39-45.
142. Kwon, C. H., Zhu, X., Zhang, J. et al. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet., 29, 410-11.
143. LaCasse, E. C., Baird, S., Korneluk, R. G., and MacKenzie, A. E. (1998). The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17, 3247-59.
144. Lachyankar, M. B., Condon, P. J., Quesenberry, P. J. et al. (2000). A role for nuclear PTEN in neuronal differentiation. J. Neurosci., 20, 1404-13.
145. LaFerla, F. M., Hall, C. K., Ngo, L., and Jay, G. (1996). Extracellular deposition of β- amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest., 98, 1626-32.
146. Lambrechts, D., Storkebaum, E., Morimoto, M. et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Gen., 34, 383-94.
147. Lashley, K. S. (1941). Thalamo-cortical connections of the rat’s brain. J. Comp. Neurol., 75, 67-121.
148. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C., and Hammond, J. (1999). Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer’s disease. J. Biol. Chem., 274, 23426-36.
149. Leist, M., Single, B., Castoldi, A. F., Kühnle, S., and Nicotera, P. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med., 185, 1481-6.
150. Lennon, S. V., Martin, S. J., and Cotter, T. G. (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif., 24, 203-14.
151. Leppin, C., Finiels-Marlier, F., Crawley, J. N., Montpied, P., and Paul, S. M. (1992). Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo. Brain Res., 581, 168-70.
152. Lesuisse, C. and Martin, L. J. (2002). Immature and mature neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J.Cereb. Blood Flow Metabol., 22, 935-50.
153. Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., and Korsmeyer, S. J. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell, 2, 183-92.
154. Levrero, M., De Laurenzi, V., Costanzo, A. et al. (2000). The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci., 113, 1661-70.
155. Lewis, J., Dickson, D. W., Lin, W. L. et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487-91.
156. Li, H., Zhu, H., Xu, C.-J., and Yuan, J. (1998). Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94, 491-501.
157. Li, M., Ona, V. O., Guegan, C. et al. (2000). Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288, 283-4.
158. Li, P., Nijhawan, D., Budihardjo, I. et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-89.
159. Liange, X. H., Kleeman, L. K., Jiang, H. H. et al. (1998). Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J. Virol., 72, 8586-96.
160. Lieberman, A. R. (1971). The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int. Rev. Neurobiol., 14, 49-124.
161. Lipton, S. A. and Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330, 613-22.
162. Liston, P., Roy, N., Tamai, K. et al. (1996). Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature, 379, 349-53.
163. Lithgow, T., van Driel, R., Bertram, J. F., and Strasser, A. (1994). The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ., 5, 411-17.
164. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86, 147-57.
165. Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89, 175-84.
166. Liu, Z., Gastard, M., Verina, T., Bora, S., Mouton, P. R., and Koliatsos, V. E. (2001). Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus. J. Comp. Neurol., 441, 1-8.
167. Lockshin, R. A. and Williams, C. M. (1964). Programmed cell death: II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J. Insect. Physiol., 10, 643-9.
168. Lockshin, R. A. and Zakeri, Z. (2001). Programmed cell death and apoptosis: origins of the theory. Nat. Rev. Mol. Cell Biol., 2, 545-50.
169. Lockshin, R. A. and Zakeri, Z. (2002). Caspase-independent cell deaths. Curr. Opin. Cell Biol., 14, 727-33.
170. Lok, J. and Martin, L. J. (2002). Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J. Neurotrauma, 19, 815-28.
171. Loo, D. T., Copani A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., and Cotman C. W. (1993). Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA, 90, 7951-5.
172. Lucas, D. R. and Newhouse, J. P. (1957). The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthal., 58, 193-201.
173. Lucassen, P. J., Chung, W. C. J., Kamphorst, W., and Swaab D. F. (1997).DNA damage distribution in the human brain as shown by in situ end labeling: area-specific differences in aging and Alzheimer’s disease in the absence of apoptotic morphology. J. Neuropathol. Exp. Neurol., 56, 887-900.
174. Majno, G. and Joris, I. (1995). Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol., 146, 3-15.
175. Maki, C. G., Huibregtse, J. M., and Howley, P. M. (1996). In vivo ubiquitination and proteasomemediated degradation of p53. Cancer Res., 56, 2649-54.
176. Martin, L. J. (1999). Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol., 58, 459-71.
177. Martin, L. J. (2000). P53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis., 7, 613-22.
178. Martin, L. J. (2001). Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med., 7, 455-78.
179. Martin, L. J. and Liu, Z. (2002). Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53- and Bax-dependent. J. Neurobiol., 50, 181-97.
180. Martin, L. J., Al-Abdulla, N. A., Brambrink, A. M., Kirsch, J. R., Sieber, F. E. and Portera-Cailliau, C. (1998). Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull., 46, 281-309.
181. Martin, L. J., Kaiser, A., and Price, A. C. (1999). Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J. Neurobiol., 40, 185-201.
182. Martin, L. J., Kaiser, A., Yu, J. W., Natale, J. E., and Al-Abdulla, N. A. (2001). Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax. J. Comp. Neurol., 433, 299-311.
183. Martin, L. J., Pardo, C. A., Cork, L. C., and Price, D. L. (1994). Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol., 145, 1358-81.
184. Martin, L. J., Price, A. C., McClendon, K. B. et al. (2003). Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. J. Neurochem., 85, 234-47.
185. Martin, L. J., Sieber, F. E., and Traystman, R. J. (2000a). Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with alterations in metabotropic glutamate receptor signaling pathways. J. Cereb. Blood Flow Metab., 20, 153-67.
186. Martin, L. J., Price, A. C., Kaiser, A., Shaikh A. Y., and Liu, Z. (2000b).Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death. Int. J. Mol. Med., 5, 3-13.
187. Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K. et al. (1994). Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron, 13, 1017-30.
188. Marzo, I., Brenner, C., Zamzami, N. et al. (1998). Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science, 281, 2027-31.
189. Mate, M. J., Ortiz-Lombardia, M., Boitel, B. et al. (2002). The crystal structure of the mouse apoptosis-inducing factor AIF. Nature Struct. Biol., 9, 442-6.
190. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitoxicity. J. Neurosci., 12, 376-89.
191. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer’s disease. Neurology, 34, 939-44.
192. McPhail, L. T., Vanderluit, J. L., McBride, C. B. et al. (2003). Endogenous expression of inhibitor of apoptosis proteins in facial motoneurons of neonatal and adult rats following axotomy. Neuroscience, 117, 567-75.
193. Merry, D. E. and Korsmeyer, S. J. (1997). Bcl-2 gene family in the nervous system. Ann. Rev. Neurosci., 20, 245-67.
194. Michaelidis, T. M., Sendtner, M., Cooper, J. D. et al. (1996). Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron, 17, 75-89.
195. Migheli, A., Atzori, C., Piva, R. et al. (1999). Lack of apoptosis in mice with ALS. Nature Med., 5, 966-7.
196. Miller, T. M., Moulder, K. L., Knudson, C. M. et al. (1997). Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol., 139, 205-17.
197. Mizushima, N., Ohsumi, Y., and Yoshimori, T. (2002). Autophagosome formation in mammalian cells. Cell Struct. Funct., 27, 421-9.
198. Morishima, Y., Gotoh, Y., Zieg, J. et al. (2001). β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci., 21, 7551-60.
199. Mouton, P. R., Martin, L. J., Calhoun, M. E., Dal Forno, G., and Price, D. L. (1998). Cognitive decline strongly correlates with cortical atrophy in Alzheimer’s disease. Neurobiol. Aging, 19, 371-7.
200. Muchmore, S.W., Sattler, M., Liang, H. et al. (1999). X-ray and NMRstructure of human Bcl-xL, an inhibitor of programmed cell death. Nature, 381, 335-41.
201. Mund, T., Gewies, A., Schoenfield, N., Bauer, M. K. A., and Grimm, S. (2003). Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J. (February 19). 10.1096/fj.02-0657fje.
202. Nagata, S. (1999). Fas ligand-induced apoptosis. Annu. Rev. Genet., 33, 29-55.
203. Nakagawa, T., Zhu, H., Morishima, N. et al. (2000). Caspase-12 mediates endoplasmic reticulumspecific apoptosis and cytotoxicity by amyloid-beta. Nature, 403, 98-103.
204. Nakajima, W., Ishida, A., Lange, M. S. et al. (2000). Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J. Neurosci., 20, 7994-8004.
205. Naruse, S., Igarashi, S., Kobayashi, H. et al. (1991). Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer’s disease. Lancet., 337, 978-9.
206. Natale, J. E., Cheng, Y., and Martin, L. J. (2002). Thalamic neuron apoptosis emerges rapidly after cortical damage in immature mice. Neuroscience, 112, 665-76.
207. Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S.-H., and Youle, R. J. (2001). Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol., 153, 1265-76.
208. Nicholson, S. J., Witherden, A. S., Hafezparast, M., Martin, J. E., and Fisher, E. M. C. (2000). Mice, the motor system, and human motor neuron pathology. Mamm. Genome, 11, 1041-52.
209. Northington, F. J., Ferriero, D. M., Graham, E. M., Traystman, R. J., and Martin, L. J. (2001). Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol. Dis., 8, 207-19.
210. O’Connor, T. M. and Wyttenbach, C. R. (1974). Cell death in the embryonic chick spinal cord. J. Cell Biol., 60, 448-59.
211. Oddo, S., Caccamo, A., Shepherd, J. D. et al. (2003). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular A_ and synaptic dysfunction. Neuron, 39, 409-21.
212. Offen, D., Beart, P. M., Cheung, N. S. et al. (1998). Transgenic mice expressing human Bcl- 2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci., 95, 5789-94.
213. Ogier-Denis, E. and Codogno, P. (2003). Autophagy: a barrier or an adaptive response to cancer. Biochim. Biophys. Acta., 1603, 113-28.
214. Olanow, C.W. and Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson’s disease. Ann. Rev. Neurosci., 22, 123-44.
215. Olkowski, Z. L. (1998). Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. NeuroReport, 9, 239-42.
216. Olney, J. W. (1971). Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J. Neuropathol. Exp. Neurol., 30, 75-90.
217. Olshansky, S. J., Carnes, B. A., and Cassel, C. K. (1993). The aging of the human species. Sci. Am., 268, 46-52.
218. Orrenius, S., Zhivotovsky, B., and Nicotera, P. (2003). Regulation of cell death: the calciumapoptosis link. Nat. Rev., 4, 552-65.
219. Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C., and LeBlanc, A. (1997). Amyloid β peptide of Alzheimer’s disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci., 16, 7533-9.
220. Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., and D’Adamio, L. (1999). Interaction of Alzheimer’s presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. J. Biol. Chem., 274, 24007-13.
221. Patrick, G. N., Zukerberg, L., Nikolic, M., de laMonte, S., Dikkes, P., and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 402, 615-22.
222. Pelvig, D. P., Pakkenberg, H., Regeur, L., Oster, S., and Pakkenberg, B. (2003). Neocortical glial cell numbers in Alzheimer’s disease. A stereological study. Dement. Geriatr. Cogn. Disord., 16, 212-19.
223. Perrelet, D., Ferri, A., Liston, P., Muzzini, P., Korneluk, R. G., and Kato, A. C. (2002). IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neuron in vivo. Nat. Cell Biol., 4, 175-9.
224. Petersen, A., Larsen, K. E., Behr, G. G. et al. (2001). Expanded CAG repeats in exon 1 of the Huntington’s disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet., 10, 1243-54.
225. Pilar, G. and Landmesser, L. (1976). Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J. Cell Biol., 68, 339-56.
226. Pompl, P. N., Yemul, S., Xiang, Z. et al. (2003). Caspase gene expression in the brain as a function of the clinical progression of Alzheimer’s disease. Arch. Neurol., 60, 369-76.
227. Poorkaj, P., Bird, T. D., Wijsman, E. et al. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 43, 815-25.
228. Portera-Cailliau, C., Price, D. L., and Martin, L. J. (1997a). Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol., 378, 70-87.
229. Portera-Cailliau, C., Price, D. L., and Martin, L. J. (1997b). Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol., 378, 88-104.
230. Pozniak, C. D., Radinovic, S., Yang, A., McKeon, F., Kaplan, D. R., and Miller, F. D. (2000). An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science, 289, 304-6.
231. Prestige, M. (1970). Differentiation, degeneration, and the role of the periphery: quantitative considerations. In The Neurosciences: Second Study Program, ed. F. O. Schmitt. New York: Rockefeller University Press, pp. 73-82.
232. Proskuryakov, S. Y., Konoplyannikov, A. G., and Gabai, V. L. (2003). Necrosis: a specific form of programmed cell death. Exp. Cell Res., 283, 1-16.
233. Prudlo, J., Koenig, J., Graser, J. et al. (2000).Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res., 897, 183-7.
234. Putcha, G. V., Deshmukh, M., and Johnson, E. M. Jr. (1999). Bax translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, Bcl-2, and caspases. J. Neurosci., 19, 7476-85.
235. Raffray, M. and Cohen, G. M. (1997). Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death? Pharmacol. Ther., 75, 153-77.
236. Raoul, C., Estvez, A. G., Nishimune, H. et al. (2002). Motoneuron death triggered by a specific pathway downstream of Fas: potentiation by ALS-linked SOD1 mutations. Neuron, 35, 1067-83.
237. Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., and Ferreira, A. (2002). Tau is essential to β-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA, 99, 6364-9.
238. Rathke-Hartlieb, S., Schlomann, U., Heimann, P., Meisler, M. H., Jockusch, H., and Bartsch, J.W. (2002). Progressive loss of striatal neurons causes motor dysfunction inMND2mutant mice and is not prevented by Bcl-2. Exp. Neurol., 175, 87-97.
239. Reddy, P. H., Williams, M., Charles, V. et al. (1998). Behavioral abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet., 20, 198-202.
240. Robertson, J.D., Enoksson, M., Suomela, M., Zhivotovsky, B., and Orrenius, S. (2002). Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem., 277, 29803-9.
241. Robison, S. H., Tandan, R., and Bradley, W. G. (1993). Repair of N-methylpurines in DNA from lymphocytes of patients with amyotrophic lateral sclerosis. J. Neurol. Sci., 115, 201-7.
242. Rohn, T. T., Rissman, R. A., Davis, M. C., Kim, Y. E., Cotman, C. W., and Head, E. (2002). Caspase-9 activation and caspase cleavage of tau in the Alzheimer’s disease brain. Neurobiol. Dis., 11, 341-54.
243. Romanes, G. J. (1946).Motor localization and the effects of nerve injury on the ventral horn cells of the spinal cord. J. Anat., 80, 117-31.
244. Rosen, D. R., Siddique, T., Patterson, D. et al. (1993).Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
245. Rosenmann, H., Meiner, Z., Kahana, E. et al. (2003). An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer’s disease. Neurosci. Lett., 340, 29-32.
246. Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu. Rev. Med., 47, 387-400.
247. Rothstein, J. D., Martin, L. J., and Kuncl, R. W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med., 326, 1464-8.
248. Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., and Kuncl, R. W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol., 38, 73-84.
249. Rowland, L. P. and Shneider, N. A. (2001). Amyotrophic lateral sclerosis. N. Engl. J. Med., 344, 1688-700.
250. Roy, N., Mahadevan, M. S., McLean, M. et al. (1995). The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell, 80, 167-78.
251. Sakahira, H., Enari, M., Ohsawa, Y., Uchiyama, Y., and Nagata, S. (1999). Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol., 9, 543-6.
252. Sano, T., Lin, H., Chen, X. et al. (1999). Differential expression ofMMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res., 59, 1820-4.
253. Sathasivam, S., Ince, P. G., and Shaw, P. J. (2001). Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol. Appl. Neurobiol., 27, 257-74.
254. Satoh, T., Nakatsuka, D., Watanabe, Y., Nagata, I., Kikuchi, H., and Namura, S. (2000). Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett., 288, 163-6.
255. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998).Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
256. Saunders, J.W. (1966). Death in embryonic systems. Science, 154, 604-12.
257. Schilling, G., Becher, M. W., Sharp, A. H. et al. (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet., 8, 397-407.
258. Schreiber, S. S., Tocco, G., Najm, I., Thompson, R. F., and Baudry, M. (1993). Cycloheximide prevents kainate-induced neuronal death and c-fos expression in adult rat brain. J. Mol. Neurosci., 4, 149-59.
259. Schwartz, L. M. and Milligan, C. E. (1996). Cold thoughts of death: the role of ICE proteases in neuronal cell death. Trends Neurosci., 19, 555-62.
260. Schwartz, L. M., Smith, S.W., Jones M. E. E. M, and Osborne, B. A. (1993). Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA, 90, 980-4.
261. Schweichel, J. U. and Merker, H. J. (1973). The morphology of various types of cell death in prenatal tissues. Teratology, 7, 253-66.
262. Scorrano, L., Oakes, S. A., Opferman, T. J. et al. (2003). Bax and Bak regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science, 300, 135-9.
263. Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. Science, 298, 789-91.
264. Selznick, L. A., Holtzman, D. M., Han, B. H. et al. (1999). In situ immunodetection of neuronal caspase-3 activation in Alzheimer’s disease. J. Neuropath. Exp. Neurol., 58, 1020-6.
265. Shaikh, A. Y. and Martin, L. J. (2002). DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in brain and spinal cord of individuals with amyotrophic lateral sclerosis. NeuroMolecular Med., 2, 47-60.
266. Sherrington, R., Rogaev, E. I., Liang, Y. et al. (1995). Cloning of a gene bearing missensemutations in early-onset familial Alzheimer’s disease. Nature, 375, 754-60.
267. Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91, 325-34.
268. Shimizu, S., Ide, T., Yanagida, T., and Tsujimoto, Y. (2000). Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J. Biol. Chem., 275, 12321-5.
269. Shimohama, S., Tanino, H., and Fujimoto, S. (2001). Differential subcellular localization of caspase family protein in the adult rat brain. Neurosci. Lett., 315, 125-8.
270. Simonian, N. A., Getz, R. L., Leveque, J. C., Konradi, C., and Coyle, J. T. (1996). Kainate induces apoptosis in neurons. Neuroscience, 74, 675-83.
271. Simons, M., Beinroth, S., Gleichmann, M. et al. (1999). Adenovirus-mediated gene transfer of inhibitors of apoptosis proteins delays apoptosis in cerebellar granule neurons. J. Neurochem., 72, 292-301.
272. Smale, G., Nichols, N. R., Brady, D. R., Finch, C. E., and Horten, W. E. Jr. (1995). Evidence for apoptotic cell death in Alzheimer’s disease. Exp. Neurol., 133, 225-30.
273. Song, Q., Kuang, Y., Dixit, V. M., and Vincenz, C. (1999). Boo, a negative regulator of cell death, interacts with Apaf-1. EMBO J., 18, 167-78.
274. Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R., Lakatta, E. G., and Longo, D. L. (1999). Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)- terminal kinase activity, and apoptosis. Mol. Cell Biol., 19, 5659-74.
275. Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brock, W., and Lassmann, H. (1999). Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease. Evidence for apoptotic cell death. Am. J. Pathol., 155, 1459-66.
276. Stanciu, M., Wang, Y., Kentor, R. et al. (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem., 275, 12200-6.
277. Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O. et al. (2000). The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA, 97, 6763-8.
278. Stennicke, H. R., Deveraux, Q. L., Humke, E. W., Reed, J. C., Dixit, V. M., and Salvesen, G. S. (1999). Caspase-9 can be activated without proteolytic processing. J. Biol. Chem., 274, 8359-62.
279. Su, J. H., Anderson, A. J., Cribbs, D. H. et al. (2003). Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death. Neurobiol. Dis., 12, 182-93.
280. Su, J. H., Zhao, M., Anderson, A. J., Srinivasan, A., and Cotman, C.W. (2001). Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology. Brain Res., 898, 350-7.
281. Susin, S. A., Lorenzo, H. K., Zamzami, N. et al. (1999).Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-6.
282. Sze, C.-I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., and Martin, L. J. (2001). NMethyl- D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease. J. Neurol. Sci., 182, 151-9.
283. Sze, C.-I., Troncoso, J. C., Kawas, C., Mouton, P., Price, D. L., and Martin, L. J. (1997). Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer’s disease. J. Neuropathol. Exp. Neurol., 56, 933-94.
284. Takashima, A., Noguchi, K., Sato, K., Hoshino, T., and Imahori, K. (1993). Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA, 90, 7789-93.
285. Tandan, R., Robison, S. H., Munzer, J. S. and Bradley, W. G. (1987). Deficient DNA repair in amyotrophic lateral sclerosis cells. J. Neurol. Sci., 79, 189-203.
286. Tata, J. R. (1966). Requirement for RNA and protein synthesis for induced regression of tadpole tail in organ culture. Dev. Biol., 13, 77-94.
287. Tatton, N. A., MaClean-Fraser, A., Tatton, W. G., Perl, D. P., and Olnanow, C. W. (1998). A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson’s disease. Ann. Neurol., 44, S142-8.
288. Tatton, W. G., Chalmers-Redman, R., Brown, D., and Tatton, N. (2003). Apoptosis in Parkinson’s disease: signals for neuronal degeneration. Ann. Neurol., 53, S61-72.
289. Tenneti, L. and Lipton, S. A. (2000). Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. Ann. Neurol., 74, 134-42.
290. Terry, R. D., Masliah, E., Salmon, D. P. et al. (1991). Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol., 30, 572-80.
291. Tomkins, J., Dempster, S., Banner, S. J., Cookson, M. R., and Shaw, P. J. (2000). Screening of AP endonuclease as a candidate gene for amyotrophic lateral sclerosis. NeuroReport, 11, 1695-7.
292. Tompkins, M. M., Basgall, E. J., Zamrini, E., and Hill, W. D. (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigra neurons. Am. J. Pathol., 150, 119-31.
293. Torvik, A. (1976). Central chromatolysis and the axon reaction. A reappraisal. Neuropathol. Appl. Neurobiol., 2, 423-32.
294. Trimmer, P. A., Smith, T. S., Jung, A. B., and Bennett, J. P. Jr. (1996). Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration, 5, 233-9.
295. Troy, C. M., Friedman, J. E., and Friedman, W. J. (2002). Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J. Biol. Chem., 277, 34295-302.
296. Trump, B. F. and Berezesky, I. K. (1996). The role of altered [Ca2+]i regulation in apoptosis, oncosis, and necrosis. Biochim. Biophys. Acta., 1313, 173-8.
297. Trump, B. J., Goldblatt, P. J., and Stowell, R. E. (1964). Studies on necrosis of mouse liver in vitro. Ultrastructural alterations in the mitochondria of hepatic parenchymal cells. Lab. Invest., 14, 343-71.
298. Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., and Davies, S. W. (2000). Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc. Natl. Acad. Sci. USA, 97, 8093-7.
299. Uberti, D., Carsana, T., Bernardi, E. et al. (2002). Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer’s disease patients. J. Cell Sci., 115, 3131-8.
300. Uetsuki, T., Takemoto, K., Nishimura, I. et al. (1999). Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci., 19, 6955-64.
301. Uppuluri, S., Knipling, L., Sackett, D. L., and Wolff, J. (1993). Localization of the colchicinebinding site of tubulin. Proc. Natl. Acad. Sci. USA, 90, 11598-602.
302. van Bekkum, D. W. (1957). The effect of x-rays on phosphorylations in vivo. Biochim. Biophys. Acta., 25, 487-92.
303. VanderHeiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., and Thompson, C. B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-37.
304. van Gurp, M., Festjens, N., van Loo, G., Saelens, X., and Vandenabeele, P. (2003).Mitochondrial intermembrane proteins in cell death. Biochem. Biophys. Res. Comm., 304, 487-97.
305. van Lookeren Campagne, M., Lucassen, P. J., Vermeulen, J. P., and Balázs, R. (1995). NMDA and kainate induced internucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur. J. Neurosci., 7, 1627-40.
306. Verhagen, A. M., Ekert, P. G., Pakusch, M. et al. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102, 43-53.
307. Verhagen, A. M., Silke, J., Ekert, P. G. et al. (2002). HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem., 277, 445-54.
308. Vila, M., Jackson-Lewis, V., Vukosavic, S. et al. (2001). Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Proc. Natl. Acad. Sci., 98, 2837-42.
309. Villunger, A., Michalak, E. M., Coultas, L. et al. (2003). P53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science, 302, 1036-8.
310. Virchow, R. (1858). Cellular Pathology as Based Upon Physiological and Pathological Histology (Translation). London: Churchill.
311. Vonsattel, J. P. and DiFiglia, M. (1998). Huntington’s disease. J. Neuropathol. Exp. Neurol., 57, 369-84.
312. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P. Jr. (1985). Neuropathological classification of Huntington’s disease. J. Neuropathol. Exp. Neurol., 44, 559-77.
313. Vukosavic, S., Dubois-Dauphin, N., Romero, N., and Przedborski, S. (1999). Bax and Bcl-2 interaction in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem., 73, 2460-8.
314. Wang, H.-G., Pathan, N., Ethell, I. M. et al. (1999). Ca2+-induced apoptosis through calcineurin dephosphorylation of Bad. Science, 284, 339-43.
315. Wang, H.-G., Rapp, U. R., and Reed, J. C. (1996). Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell, 87, 629-38.
316. Wei, M. C., Zong, W-X., Cheng, E. H.-Y. et al. (2001). Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-30.
317. Weidemann, A., Paliga, K., Drrwang, U. et al. (1999). Proteolytic processing of the Alzheimer’s disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem., 274, 5823-9.
318. West, M. J., Kawas, C. H., Martin L. J., and Troncoso, J. C. (2000). The CA1 region of the human hippocampus is a hot spot in Alzheimer’s disease. Ann. NY Acad. Sci., 908, 255-9.
319. White, E. and Prives, C. (1999). DNA damage enables p73. Nature, 399, 734-7.
320. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A.W., Coyle, J. T., and DeLong, M. R. (1982). Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-9.
321. Widmann, C., Gerwins, P., Johnson, N., Jarpe, M. B., and Johnson, G. L. (1998). MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell Biol., 18, 2416-29.
322. Wolf, B. B. and Green, D. R. (1999). Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem., 274, 20049-52.
323. Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., and Youle, R. L. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139, 1281-92.
324. Wong, P. C., Cai, H., Borchelt, D. R., and Price, D. L. (2002). Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci., 5, 633-9.
325. Wong, P. C., Pardo, C. A., Borchelt, D. R. et al. (1995). An adverse property of a familial ALSlinked SOD1mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, 1105-16.
326. Wüllner, U., Kornhuber, J., Weller, M. et al. (1999). Cell death and apoptosis regulating proteins in Parkinson’s disease - a cautionary note. Acta. Neuropathol., 97, 408-12.
327. Wyllie, A. H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-6.
328. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. (1980). Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
329. Xanthoudakis, S. and Curran, T. (1992). Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J., 11, 653-65.
330. Xiang, H., Kinoshita, Y., Knudson, C. M., Korsmeyer, S. J., Schwartzkroin, P. A., and Morrison, R. S. (1998). Bax involvement in p53-mediated neuronal cell death. J.Neurosci., 18, 1363-73.
331. Xu, D. G., Korneluk, R. G., Tamai, K. et al. (1997). Distribution of neuronal apoptosis inhibitory protein-like immune reactivity in the rat central nervous system. J. Comp. Neurol., 382, 247-59.
332. Xu, J., Kao, S. Y., Lee, F. J., Song, W., Jin, L.W., and Yankner, B. A. (2002). Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med., 8, 600-6.
333. Xue, L. Z., Fletcher, G. C., and Tolkovsky, A. M. (1999). Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell Neurosci., 14, 180-98.
334. Yaar, M., Zhai, S., Fine, R. E. et al. (2002). Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem., 277, 7720-5.
335. Yan, X. X., Najbauer, J., Woo, C. C., Dashtipour, K., Ribak, C. E., and Leon, M. (2001). Expression of active caspase-3 in mitotic and postmitotic cells or rat forebrain. J. Comp. Neurol., 433, 4-22.
336. Yang, A., Walker, N., Bronson, R. et al. (2000). p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumors. Nature, 404, 99-103.
337. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-91.
338. Yang, J., Liu, X., Bhalla, K. et al. (1997). Prevention of apoptosis by bcl-2: release of cytochrome c frommitochondria blocked. Science, 275, 1129-32.
339. Yang, L., Matthews, R. T., Schulz, J. B. et al. (1998). 1-methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci., 18, 8145-52.
340. Yankner, B. A., Dawes, L. R., Fisher, S. et al. (1989). Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science, 245, 417-20.
341. Yoshio, H., Kong, Y.-Y., Yoshida, R. et al. (1998). Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94, 739-50.
342. Younkin, S. G. (1995). Evidence that A beta 42 is the real culprit in Alzheimer’s disease. Ann. Neurol., 37, 287-8.
343. Yu, Z. X., Li, S. H., Evans, J., Pillarsetti, A., Li, H., and Li, X. J. (2003). Mutant huntingtin causes context - dependent neurodegeneration in mice with Huntington’s disease. J. Neurosci., 23, 2193-202.
344. Yuan, J., Lipinski, M., and Degterev, A. (2003). Diversity in the mechanisms of neuronal cell death. Neuron, 40, 401-13.
345. Yue, Z., Horton, A., Bravin, M., DeJager, P. L., Selimi, F., and Heintz, N. (2002). A novel protein complex linking the δ2 glutamate receptor and autophagy: implications for neurodegeneration in Lurcher mice. Neuron, 35, 921-33.
346. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-xL. Cell, 87, 619-28.
347. Zhang, Y., McLaughlin, R., Goodyer, C., and LeBlanc, A. (2002). Selective cytotoxicity of intracellular amyloid β peptide1−42 through p53 and Bax in cultured primary human neurons. J. Cell Biol., 156, 519-29.
348. Zong, W.-X., Li, C., Hatzivassiliou, G. et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol., 162, 59-69.
349. Zou, H., Li, Y., Liu, X., and Wang, X. (1999). An Apaf-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem., 274, 11549-56.
350. Zuch, C. L., Nordstroem, V. K., Briedrick, L. A., Hoering, G. R., Granholm, A.-C., and Bickford, P. C. (2000). Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J. Comp. Neurol., 427, 440-54.